Peroxiredoxin 1 mRNA (PRDX1 mRNA)

Peroxiredoxin 1 (PRDX1) mRNA encodes a member of the peroxiredoxin family of antioxidant enzymes, which are essential for maintaining cellular redox homeostasis by reducing hydrogen peroxide and organic hydroperoxides [1][2]. The resulting PRDX1 protein also functions as a molecular chaperone and a regulator of signal transduction pathways, interacting with proteins such as PTEN and c-Myc to influence cell growth and survival [1][4]. In various malignancies, including lung, breast, and prostate cancers, PRDX1 mRNA is significantly overexpressed, providing a survival advantage to tumor cells by protecting them from oxidative stress and therapeutic-induced apoptosis [3][4]. Targeting PRDX1 mRNA using RNA-based therapeutics like antisense oligonucleotides (ASOs) or small interfering RNAs (siRNAs) aims to downregulate protein expression, thereby sensitizing cancer cells to oxidative damage and enhancing the efficacy of chemotherapy and radiation [3]. While currently in the experimental stage, PRDX1 mRNA represents a promising target for precision oncology and potentially for treating inflammatory conditions where oxidative stress plays a central role [2][4]. (Sources: [1] UniProt Q06830; [2] NCBI Gene 5052; [3] PMID: 23653360; [4] PMID: 28213511)

Other names

PAG mRNAPAGA mRNAPAGB mRNAPRX1 mRNAPRXI mRNATDPX2 mRNAMSP23 mRNANKEFA mRNAProliferation-associated gene mRNANatural killer cell-enhancing factor A mRNA

RNA interference (siRNA-mediated degradation), RNase H-mediated cleavage (ASO-mediated degradation), Translation inhibition